Xortx Therapeutics Q1 Financial Snapshot
Company Announcements

Xortx Therapeutics Q1 Financial Snapshot

Xortx Therapeutics (TSE:XRTX) has released an update.

Xortx Therapeutics has released its financial statements for the first quarter of 2024, showing a total asset increase to $6.05 million from the end of the previous year. However, the company also reported an increase in total liabilities to $3.56 million and a comprehensive loss, including research and development expenses, totaling over $1.08 million before other items. This report highlights the financial movements and challenges faced by the company as it navigates through the fiscal year.

For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskXORTX Outlines Executive Compensation Strategy
TipRanks Auto-Generated NewsdeskXORTX Therapeutics Plans Major Warrant Repricing
TipRanks Auto-Generated NewsdeskXORTX Therapeutics Showcases Progress at BIO 2024
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!